Healthcare - Biotechnology - NASDAQ - US
$ 3.99
-3.39 %
$ 178 M
Market Cap
-1.27
P/E
Price Target
Average
125.56%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
--3.74%
Net Income
Estimate
20.34%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Verastem, Inc.
Wall Street analysts predict an average 1-year price target for VSTM of $9 , with forecasts ranging from a low of $5 to a high of $13 .
VSTM Lowest Price Target
Wall Street Target
5 USD
25.31%
VSTM Average Price Target
Wall Street Target
9 USD
125.56%
VSTM Highest Price Target
Wall Street Target
13 USD
225.81%
REVENUE FORECAST
Revenue Forecast Chart VSTM
EBIT FORECAST
EBIT Forecast Chart VSTM
NET INCOME FORECAST
Net Income Chart VSTM